QuantLogix

ABBV vs BMY — live signal comparison

Head-to-head on QuantLogix's 5-factor quant engine, recomputed throughout the trading day. An engine-read comparison — not a recommendation.

ABBV
ABBVIE INC.
59/100
BUY
$256.91 · -0.90% · $458.2B
50% of similar setups up in 5d
Full scorecard →
VS
engine lead
BMY
Bristol-Myers Squibb Co.
66/100
STRONG BUY
$62.56 · +0.76% · $126.8B
46% of similar setups up in 5d
Full scorecard →
Factor by factor — ABBV (left) vs BMY (right)
63
Technical
73
56
Momentum
55
58
Fundamental
67
19
Options
67
46
Microstructure
63

QuantLogix's 5-factor engine currently reads ABBVIE INC. (ABBV) at 59/100 (buy) and Bristol-Myers Squibb Co. (BMY) at 66/100 (strong buy). BMY carries the stronger composite read by 7 points, led by technical at 73/100. ABBV's strongest leg is technical at 63/100. In pattern backtesting, 50% of 50 ABBV setups and 46% of 50 BMY setups rose within five trading days. Signals recompute throughout the trading day — the balance can shift with the tape.

Track BMY with free signal alerts Browse all scorecards
🤖 Want the deeper take? Pro runs a 10-agent AI debate on either name — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. ABBV scorecard · BMY scorecard · ABBV earnings · BMY earnings · Today's movers · Verified track record